These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 15905202)

  • 1. Overexpression of Id-1 in prostate cancer cells promotes angiogenesis through the activation of vascular endothelial growth factor (VEGF).
    Ling MT; Lau TC; Zhou C; Chua CW; Kwok WK; Wang Q; Wang X; Wong YC
    Carcinogenesis; 2005 Oct; 26(10):1668-76. PubMed ID: 15905202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK; Poon RT; Yuen AP; Ling MT; Wang XH; Wong YC; Guan XY; Man K; Tang ZY; Fan ST
    Clin Cancer Res; 2006 Dec; 12(23):6910-9. PubMed ID: 17145808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones.
    Guo Y; Wang S; Hoot DR; Clinton SK
    J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Id-1 expression induces androgen-independent prostate cancer cell growth through activation of epidermal growth factor receptor (EGF-R).
    Ling MT; Wang X; Lee DT; Tam PC; Tsao SW; Wong YC
    Carcinogenesis; 2004 Apr; 25(4):517-25. PubMed ID: 14688027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of bone marrow-derived endothelial cell precursors in spontaneous prostate tumors varies with tumor grade.
    Li H; Gerald WL; Benezra R
    Cancer Res; 2004 Sep; 64(17):6137-43. PubMed ID: 15342397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bombesin stimulates nuclear factor kappa B activation and expression of proangiogenic factors in prostate cancer cells.
    Levine L; Lucci JA; Pazdrak B; Cheng JZ; Guo YS; Townsend CM; Hellmich MR
    Cancer Res; 2003 Jul; 63(13):3495-502. PubMed ID: 12839933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage-specific characterization of the vascular endothelial growth factor axis in prostate cancer: expression of lymphangiogenic markers is associated with advanced-stage disease.
    Kaushal V; Mukunyadzi P; Dennis RA; Siegel ER; Johnson DE; Kohli M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):584-93. PubMed ID: 15701844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclooxygenase-2 promotes prostate cancer progression.
    Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
    Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiogenically active vascular endothelial growth factor is over-expressed in malignant human and rat prostate carcinoma cells.
    Chen HJ; Treweeke AT; Ke YQ; West DC; Toh CH
    Br J Cancer; 2000 May; 82(10):1694-701. PubMed ID: 10817506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Keratinocyte growth factor induces vascular endothelial growth factor-A expression in colorectal cancer cells.
    Narita K; Fujii T; Ishiwata T; Yamamoto T; Kawamoto Y; Kawahara K; Nakazawa N; Naito Z
    Int J Oncol; 2009 Feb; 34(2):355-60. PubMed ID: 19148469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential autocrine role for vascular endothelial growth factor in prostate cancer.
    Jackson MW; Roberts JS; Heckford SE; Ricciardelli C; Stahl J; Choong C; Horsfall DJ; Tilley WD
    Cancer Res; 2002 Feb; 62(3):854-9. PubMed ID: 11830543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes.
    Huang YQ; Li JJ; Hu L; Lee M; Karpatkin S
    Thromb Haemost; 2001 Oct; 86(4):1094-8. PubMed ID: 11686329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of MAPK signaling pathway is essential for Id-1 induced serum independent prostate cancer cell growth.
    Ling MT; Wang X; Ouyang XS; Lee TK; Fan TY; Xu K; Tsao SW; Wong YC
    Oncogene; 2002 Dec; 21(55):8498-505. PubMed ID: 12466969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
    Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
    Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutralizing anti-vascular endothelial growth factor antibody inhibits further growth of established prostate cancer and metastases in a pre-clinical model.
    Melnyk O; Zimmerman M; Kim KJ; Shuman M
    J Urol; 1999 Mar; 161(3):960-3. PubMed ID: 10022734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor overexpression by soft tissue sarcoma cells: implications for tumor growth, metastasis, and chemoresistance.
    Zhang L; Hannay JA; Liu J; Das P; Zhan M; Nguyen T; Hicklin DJ; Yu D; Pollock RE; Lev D
    Cancer Res; 2006 Sep; 66(17):8770-8. PubMed ID: 16951193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association of Id-1, MIF and GSTpi with acquired drug resistance in hormone independent prostate cancer cells.
    Lin JC; Chang SY; Hsieh DS; Lee CF; Yu DS
    Oncol Rep; 2005 May; 13(5):983-8. PubMed ID: 15809768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
    Cash J; Korchnak A; Gorman J; Tandon Y; Fraizer G
    Oncol Rep; 2007 Jun; 17(6):1413-9. PubMed ID: 17487399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.